Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AxyS claims new caspase activators and their use in cancer and other disorders

Feb. 18, 2004

Ariad highlights AP-23573 product development progress over past year

Feb. 18, 2004

Xenova studies selective MRP1 inhibitors for multidrug resistance in cancer

Feb. 18, 2004

Erbitux receives FDA approval

Feb. 17, 2004

Allergan patent covers antitumor agents for breast and prostate cancer therapy

Feb. 17, 2004

Indian scientists claim new anthramycin-based antitumor agents

Feb. 17, 2004

Good safety profile reported for BBR-3576 in patients with advanced solid tumors

Feb. 17, 2004

Novel antitumor agents in early development at Zentaris

Feb. 16, 2004

Third of four phase II trials initiated for PI-88

Feb. 13, 2004

Allergan plans IND filing for Peplin's topical drug for actinic keratosis

Feb. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...